Featured news in The Life Sciences Report



RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference (1/17/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Biotech Stock Roundup: Juno Surges on Acquisition Rumor, Concert Down on Patent News (1/17/2018)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis (1/17/2018)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Lands Commitment for Key Investment Partnership (1/16/2018)

view
 


RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth (1/16/2018)

view
 


Celgene Corp. (CELG:NASDAQ)
Concert Pharmaceuticals Plunges on Patent Petition Setback (1/15/2018)

view
 

Celgene Corp. (CELG:NASDAQ)
4 ETFs Set to Surge in Q4 Earnings (1/15/2018)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of AmnioFix® Injectable In Patients With Recalcitrant Plantar Fasciitis Pain (1/16/2018)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm to Present at Precision Medicine World Conference 2018 Silicon Valley on January 22 (1/16/2018)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Company's Therapy Attacks Only Harmful Brain Protein, Unlike Other Treatments, Study Finds (1/11/2018)

view